Key result
Preoperative statins linked to ~67% lower operative mortality following coronary revascularization.
Why the study?
Numerous studies suggested statins have beneficial non-lipid-lowering effects including reducing systemic inflammatory response after surgery, but their effect on complications and operative mortality after coronary revascularization needed evaluation.
Does preoperative statin treatment reduce operative mortality and complications in patients undergoing coronary arterial revascularization?
Cohort (n=720)
Does preoperative statin treatment reduce operative mortality and complications in patients undergoing coronary arterial revascularization?
Preoperative statin therapy is associated with significantly lower operative mortality in patients undergoing coronary artery bypass grafting.
Answers are grounded in this paper and cite their sources.
Preoperative statin use was associated with lower CABG mortality; leaves open whether this warrants routine preoperative initiation pending randomized confirmation.
OBJECTIVES: Numerous studies have suggested that statins have beneficial non-lipid-lowering effects, including reduction of systemic inflammatory response following surgery. We wanted to evaluate the effect of preoperative statin treatment on complications and operative mortality after coronary arterial revascularization. DESIGN: We performed a retrospective study of 720 consecutive patients who underwent on-pump coronary artery bypass grafting (CABG) (n = 513) or off-pump (OPCAB) (n = 207) in Iceland from 2002-2006. Patients taking statins preoperatively (n = 529) were compared with those not taking statins (n = 191). Predictors of complications and operative mortality were evaluated by univariate and multivariate analysis. RESULTS: Cardiovascular risk profiles were similar. However, hypertension was more common in the statin group but EuroSCORE was slightly lower. Operative mortality was significantly lower in patients taking statins (1.7% vs. 5.8%, p < 0.001). There were no significant differences in the incidence of major complications. Multivariate analysis showed that preoperative statin treatment was an independent predictor of lower operative mortality (OR = 0.33, p = 0.043), even after adjusting for EuroSCORE, acute operations, advanced age, or other medications. CONCLUSIONS: In this non- randomized study, patients taking statins had lower operative mortality than the controls after adjusting for multiple confounders. The reason for this might be linked to pleiotropic effects of statins.
No takes yet. Share an insight, caveat, or question.
Oddsson et al. (2012) conducted a cohort in Coronary arterial revascularization (n=720). Preoperative statin treatment vs. Not taking statins was evaluated on Operative mortality (OR 0.33, p=0.043). Preoperative statin treatment was associated with lower operative mortality following coronary revascularization compared to no statins.
Synapse has enriched 10 related papers. Consider them for comparative context: